insilTox ApS: Financial statements 2023
CVR: 36996641
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
insilTox ApS (CVR 36996641) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 209,293 and a net result of DKK -7,701 compared with DKK 2,786 the year before. That is an increase of 49.9% compared with the year before. Equity in the 2023 report amounted to DKK 39,635. The solvency ratio was 65.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 209,293
- Profit/Loss
- DKK -7,701
- Equity
- DKK 39,635
- Total Assets
- DKK 60,864
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 209K | -8K | 40K | 1 |
| 2022 | - | 140K | 3K | 47K | 1 |
| 2021 | - | 78K | -28K | 45K | 1 |
| 2020 | - | 137K | 43K | 72K | 1 |
| 2019 | - | 199K | -38K | 29K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
InsilTox ApS has published its annual report for 2022. Gross profit came to DKK 139,632, and the net result was DKK 2,786.
About insilTox ApS
insilTox ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2015. The company is registered under the industry Anden teknisk rådgivning. The management consists of Svava Osk Jonsdottir. The company is owned by insilTox Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 158,376 and a net result of DKK 3,502 compared with DKK 3,861 the year before. Equity in the 2025 report amounted to DKK 46,998.